SAN DIEGO, July 30 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc.
(NYSE: BMR), a real estate investment trust focused on providing real
estate to the life science industry, today announced financial results for
the second quarter ended June 30, 2008.
Highlights:
-- Funds from operations (FFO) for the quarter were $34.5 million, or
$0.47 per diluted share
-- Executed 14 leasing transactions during the quarter representing gross
leasing volume of approximately 327,000 square feet, up from 127,000
square feet of gross leasing volume in the prior quarter:
o Nine new leases totaling approximately 224,000 square feet --
including a 10-year, 144,000 square foot lease with DayStar
Technologies, Inc. at the Pacific Research Center
o Five leases amended to extend their terms totaling approximately
103,000 square feet
-- Achieved substantial completion of core and shell construction at three
of our development properties:
o Two of the three buildings under construction at our Landmark at
Eastview campus in New York, representing 230,000 square feet and
leased to Regeneron Pharmaceuticals, Inc.
o 94,000 square foot laboratory and office facility at our 530
Fairview Avenue property in Seattle
o 84,000 square foot laboratory and office facility at our Towne
Centre Drive campus in San Diego ahead of schedule, with Illumina,
Inc. taking partial occupancy in July 2008
-- Initiated deliveries of space to four tenants, Beth Israel Deaconess
Medical Center, Inc., Children's Hospital Corporation, Dana Farber<
'/>"/>
| SOURCE BioMed Realty Trust, Inc. Copyright©2008 PR Newswire. All rights reserved |